Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 4 EP applications Rie Kondo has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11784095

NOVEL PROCESSES

IPC classification:
C07D 239/70
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
The patent has been granted
EP11847368

COMPOUNDS

IPC classification:
A61K 31/4412, A61K 31/513, A61P 9/10, C07D 213/69, C07D 239/52, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/06
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11826309

TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES

IPC classification:
A61K 31/519, A61P 3/08, A61P 7/00, A61P 25/00, A61P 27/02, C07D 471/04
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11802872

PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP-PLA2

IPC classification:
C07D 239/36, C07D 239/47, C07D 239/52, C07D 239/56, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/06, C07D 403/12, C07D 403/14, C07D 413/06, C07D 417/06
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature